Estimate of the cost per responder for treatment with biological therapies of moderate-to-severe plaque psoriasis in Colombia for first-year and maintenance periods-Reference-Cited by-同舟云学术

Estimate of the cost per responder for treatment with biological therapies of moderate-to-severe plaque psoriasis in Colombia for first-year and maintenance periods

Published:2023-03-29 Issue:5 Volume:23 Page:511-517
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Lasalvia Pieralessandro¹^ORCID,Gil-Rojas Yaneth¹,Papadimitropoulos Emmanuel²³,Burge Russel⁴⁵,Rosselli Diego¹⁶^ORCID

Affiliation:

1. Department of Health Economics, Neuroeconomix, Bogota, Colombia

2. Value Evidence and Outcomes, Eli Lilly and Company, Toronto, ON, Canada

3. Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada

4. Value Evidence and Outcomes, Eli Lilly and Company, Indianapolis, Indiana, USA

5. Division of Pharmaceutical Sciences, University of Cincinnati, Cincinnati, Ohio, USA

6. Faculty of Medicine, Department of Clinical Epidemiology and Biostatistics, Pontificia Universidad Javeriana, Hospital San Ignacio, Bogota, Colombia

Funder

NeuroEconomix received funding from Eli Lilly and Cmopany for this study

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2023.2190514

Reference30 articles.

1. Organization WH. Global report on psoriasis [Internet]. Geneva: World Health Organization; 2016 [cited 2023 March 28]. Available from: https://apps.who.int/iris/handle/10665/204417

2. Psoriasis

3. Alcohol consumption and smoking in relation to psoriasis: a Mendelian randomization study

4. Smoking and Psoriasis: From Epidemiology to Pathomechanisms

5. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics